- Home
- AGFY vs ENZ Comparison
AGFY vs ENZ Comparison
Compare AGFY & ENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGFY
- ENZ
- Stock Information
- Founded
- AGFY 2016
- ENZ 1976
- Country
- AGFY United States
- ENZ United States
- Employees
- AGFY N/A
- ENZ N/A
- Industry
- AGFY Military/Government/Technical
- ENZ Medical Specialities
- Sector
- AGFY Consumer Discretionary
- ENZ Health Care
- Exchange
- AGFY Nasdaq
- ENZ Nasdaq
- Market Cap
- AGFY 41.0M
- ENZ 34.2M
- IPO Year
- AGFY 2021
- ENZ N/A
- Fundamental
- Price
- AGFY $18.25
- ENZ $0.31
- Analyst Decision
- AGFY
- ENZ
- Analyst Count
- AGFY 0
- ENZ 0
- Target Price
- AGFY N/A
- ENZ N/A
- AVG Volume (30 Days)
- AGFY 8.4K
- ENZ 625.0K
- Earning Date
- AGFY 05-20-2025
- ENZ 06-12-2025
- Dividend Yield
- AGFY N/A
- ENZ 31.59%
- EPS Growth
- AGFY N/A
- ENZ N/A
- EPS
- AGFY N/A
- ENZ N/A
- Revenue
- AGFY $9,680,000.00
- ENZ $29,094,000.00
- Revenue This Year
- AGFY N/A
- ENZ N/A
- Revenue Next Year
- AGFY N/A
- ENZ N/A
- P/E Ratio
- AGFY N/A
- ENZ N/A
- Revenue Growth
- AGFY N/A
- ENZ N/A
- 52 Week Low
- AGFY $2.71
- ENZ $0.25
- 52 Week High
- AGFY $84.44
- ENZ $1.27
- Technical
- Relative Strength Index (RSI)
- AGFY 48.92
- ENZ 39.61
- Support Level
- AGFY $17.20
- ENZ $0.26
- Resistance Level
- AGFY $18.79
- ENZ $0.42
- Average True Range (ATR)
- AGFY 1.01
- ENZ 0.07
- MACD
- AGFY 0.12
- ENZ 0.01
- Stochastic Oscillator
- AGFY 63.74
- ENZ 35.29
About AGFY Agrify Corporation
Agrify Corp is a leading provider of innovative cultivation and extraction solutions for the cannabis industry, bringing data, science, and technology to the forefront of the market. Its proprietary micro-environment-controlled Agrify Vertical Farming Units (VFUs) enable cultivators to produce high-quality products The products offered by the company include Integrated Grow Racks, LED Grow Lights, Hydroponics, and Vertical Farming Units.
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.